These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30003677)

  • 1. Bilateral uveal melanoma: hunting for the source.
    Shields CL; Masoomian B; Shields JA
    Clin Exp Ophthalmol; 2018 Jul; 46(5):459-461. PubMed ID: 30003677
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of Immunocytochemistry of BRCA1-associated Protein-1 (BAP1) With Other Prognostic Markers in Uveal Melanoma.
    Glasgow BJ; McCannel TA
    Am J Ophthalmol; 2018 May; 189():122-126. PubMed ID: 29530782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular alternations in uveal melanoma.
    Materin MA; Faries M; Kluger HM
    Curr Probl Cancer; 2011; 35(4):211-24. PubMed ID: 21911184
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of somatic mutations and chromosomal aberrations in the prognosis of uveal melanoma in a Spanish patient cohort.
    Silva-Rodríguez P; Bande M; Fernández-Díaz D; Lago-Baameiro N; Pardo M; José Blanco-Teijeiro M; Domínguez F; Loidi L; Piñeiro A
    Acta Ophthalmol; 2021 Nov; 99(7):e1077-e1089. PubMed ID: 33421325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of advanced genetic testing for clinical prognostication in uveal melanoma.
    Werdich XQ; Jakobiec FA; Singh AD; Kim IK
    Semin Ophthalmol; 2013; 28(5-6):361-71. PubMed ID: 24010756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
    Szalai E; Wells JR; Ward L; Grossniklaus HE
    Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveal Melanoma in BAP1 Tumor Predisposition Syndrome: Estimation of Risk.
    Singh N; Singh R; Bowen RC; Abdel-Rahman MH; Singh AD
    Am J Ophthalmol; 2021 Apr; 224():172-177. PubMed ID: 33316260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
    Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
    JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases.
    Aoude LG; Vajdic CM; Kricker A; Armstrong B; Hayward NK
    Pigment Cell Melanoma Res; 2013 Mar; 26(2):278-9. PubMed ID: 23171164
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimating Cured Fractions of Uveal Melanoma.
    Singh AD; Zabor EC; Radivoyevitch T
    JAMA Ophthalmol; 2021 Feb; 139(2):174-181. PubMed ID: 33355644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
    Marušić Z; Buljan M; Busam KJ
    J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving risk estimates of metastasis from uveal melanoma through mutation profiling.
    Kivelä T; Jager MJ
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(8):5168. PubMed ID: 25143043
    [No Abstract]   [Full Text] [Related]  

  • 15. Germline BAP1 alterations in familial uveal melanoma.
    Rai K; Pilarski R; Boru G; Rehman M; Saqr AH; Massengill JB; Singh A; Marino MJ; Davidorf FH; Cebulla CM; H Abdel-Rahman M
    Genes Chromosomes Cancer; 2017 Feb; 56(2):168-174. PubMed ID: 27718540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.
    Shahriyari L; Abdel-Rahman M; Cebulla C
    PLoS One; 2019; 14(2):e0211507. PubMed ID: 30716094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage response proteins and its role in tumor progression of uveal melanoma with patient outcome.
    Kashyap S; Jha J; Singh MK; Singh L; Sen S; Kaur J; Bajaj MS; Pushker N
    Clin Transl Oncol; 2020 Sep; 22(9):1472-1480. PubMed ID: 32124242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline BAP1 mutations also predispose to cutaneous squamous cell carcinoma.
    Rawson RV; Watson GF; Maher AM; McCarthy SW; Thompson JF; Scolyer RA
    Pathology; 2017 Aug; 49(5):539-542. PubMed ID: 28693747
    [No Abstract]   [Full Text] [Related]  

  • 19. BAP1 Germline Mutations in Finnish Patients with Uveal Melanoma.
    Turunen JA; Markkinen S; Wilska R; Saarinen S; Raivio V; Täll M; Lehesjoki AE; Kivelä TT
    Ophthalmology; 2016 May; 123(5):1112-7. PubMed ID: 26876698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Gene Mutation Status with Copy Number Profile in Uveal Melanoma.
    Yavuzyigitoglu S; Drabarek W; Smit KN; van Poppelen N; Koopmans AE; Vaarwater J; Brands T; Eussen B; Dubbink HJ; van Riet J; van de Werken HJ; Beverloo B; Verdijk RM; Naus N; Paridaens D; Kilic E; de Klein A;
    Ophthalmology; 2017 Apr; 124(4):573-575. PubMed ID: 27916271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.